Pranlukast: a review of its use in the management of asthma.
about
Antileukotriene agents compared with placebo in children and adults with mild asthmaCysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System DisordersCysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell functionLipoxygenase inhibitors for the treatment of pancreatic cancer.Improving dissolution and oral bioavailability of pranlukast hemihydrate by particle surface modification with surfactants and homogenization.A Case of Pranlukast-Induced Anaphylactic Shock.Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers.Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.Non-corticosteroid therapy for the long-term control of asthma.Comparative clinical evaluation of ketotifen and montelukast sodium in asthmatic Iraqi patients.CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors.Efficacy and Safety of Modified Pranlukast (Prakanon(®)) Compared with Pranlukast (Onon(®)): A Randomized, Open-Label, Crossover Study.Cysteinyl Leukotriene Receptor 1/2 Antagonists Nonselectively Modulate Organic Anion Transport by Multidrug Resistance Proteins (MRP1-4).Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats.Leukotriene Receptor Antagonists Inhibit Mitogenic Activity in Triple Negative Breast Cancer Cells
P2860
Q24187545-8E2DCBAE-4955-405F-9857-A37C2674B164Q28278005-7C3F1CF0-7F29-4F3B-93BA-75D67D3CBACBQ33757657-FB2C647E-81C5-4A1D-BB6B-B552C2BC15A3Q35204970-038629AC-7DA2-4439-9A90-6EE3C46240ADQ35794501-84DB5B36-2C5A-4315-9A7F-35ED53ACE337Q36636612-EC81C896-5A97-4281-B865-D72BF05B82A5Q36775615-B04030C0-C189-4DB0-A564-F4BB5FFE2D40Q36892408-505D0DED-8EC6-4D0C-B4CC-632D73EE6AB2Q36916911-58014672-B096-4B47-A668-D1062650E72EQ37063284-43E55E1E-4D5B-4A72-9CA7-E729D7202BD2Q37140406-F5217DE4-72E9-4BA9-9AEF-BEE174D4D7E7Q39514299-0BF48FFF-ED98-415F-837E-89F2810F51DBQ45348897-76B36D3C-5C4C-4248-AAF1-EA0618BD26F5Q46616233-A9C943C1-7D6F-46B6-A3FB-E7D9C52B833CQ52723870-CAC29FF6-D6C8-46ED-845F-AC2C207FDF89
P2860
Pranlukast: a review of its use in the management of asthma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pranlukast: a review of its use in the management of asthma.
@ast
Pranlukast: a review of its use in the management of asthma.
@en
type
label
Pranlukast: a review of its use in the management of asthma.
@ast
Pranlukast: a review of its use in the management of asthma.
@en
altLabel
Pranlukast
@en
prefLabel
Pranlukast: a review of its use in the management of asthma.
@ast
Pranlukast: a review of its use in the management of asthma.
@en
P1433
P1476
Pranlukast: a review of its use in the management of asthma.
@en
P2093
Karen L Goa
Susan J Keam
P304
P356
10.2165/00003495-200363100-00005
P577
2003-01-01T00:00:00Z
P6179
1044716377